AXSM

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Anavex Life Sciences (AVXL – Research Report) and Axsome Therapeutics (AXSM – Research Report) with bullish sentiments. Anavex Life Sciences (AVXL) In a report issued on November 28, Yun Zhong from BTIG maintained a Buy rating on Anavex Life Sciences, with a price target of $35.00. The company's shares closed last Tuesday at $8.94, close to its 52-week low of $7.13. According to TipRanks.
https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-223?utm_source=advfn.com&utm_medium=referral